Coccidioidomycosis: Host response and vaccine development

Clinical Microbiology Reviews

Volumn 17, Issue 4, 2004, Pages 804-839

  Cox, Rebecca A ^a   Magee, D Mitchell ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

27K PROTEIN; ADJUVANT; AG2 PROTEIN; ALUMINUM POTASSIUM SULFATE; BETA 1,3 GLUCANOSYLTRANSFERASE; COCCIDIODES SPECIFIC ANTIGEN; COMPLEMENTARY DNA; CYTOSINE PHOSPHATE GUANINE OLIGONUCLEOTIDE; DINUCLEOTIDE; ELI ANTIGEN 1; EXPRESSION LIBRARY IMMUNIZATION ANTIGEN 1; FORMALIN KILLED SPHERULE VACCINE; FUNGUS ANTIGEN; FUNGUS VACCINE; GEL 1 PROTEIN; GENE VACCINE; HEAT SHOCK PROTEIN 60; PHOSPHORYL LIPID A; PRA CDNA PVR1020 VACCINE; PROLINE RICH ANTIGEN; QS 21; RIBI 700; SOWGP PROTEIN; UNCLASSIFIED DRUG; UREASE;

CLINICAL TRIAL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; CONIDIUM; CPG ISLAND; DRUG DEVELOPMENT; DRUG SCREENING; EMULSION; GENE; GENETIC SCREENING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LIFE CYCLE; MYCELIUM; REVIEW; SOWGP GENE; TH1 CELL; URE GENE;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; FUNGAL VACCINES; HUMANS;

ANIMALIA; COCCIDIOIDES; FUNGI;

EID: 5644240775     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.4.804-839.2004     Document Type: Review

References (326)

1. Abuodeh. R. O., L. F. Shubitz, E. Siegel, S. Snyder, T. Peng, K. I. Orsborn, E. Brummer, D. A. Stevens, and J. N. Galgiani. 1999. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect. Immun. 67:2935-2940.
2. Albert, E. D., M. R. Mickey, and P. I. Terasaki. 1973. Genetics of the HLA system in four populations: American-Caucasians, Japanese-Americans, American Negroes, and Mexican Americans, p. 233-240. In J. Dausett and J. Colombani (ed.), Histocompatibility testing. The Williams & Wilkins Co., Baltimore, Md.
3. Ampel, N. M. 1996. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg. Infect. Dis. 2:109-116.
4. Ampel, N. M. 1994. In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules. Cell. Immunol. 153:248-255.
5. Ampel, N. M., and L. Christian. 2000. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med. Mycol. 38:127-132.
6. Ampel, N. M., C. L. Dois, and J. N. Galgiani. 1993. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am. J. Med. 94:235-240.
7. Ampel, N. M., and J. N. Galgiani. 1991. Interaction of human peripheral blood mononuclear cells with Coccidioides immitis arthroconidia. Cell Immunol. 133:253-262.
8. Ampel, N. M., L. A. Kramer, K. M. Kerekes, S. M. Johnson, and D. Pappagianis. 2001. Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med. Mycol. 39:315-320.
9. Ampel, N. M., L. A. Kramer, L. Li, D. S. Carroll, K. M. Kerekes, S. M. Johnson, and D. Pappagianis. 2002. In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K. Clin. Diagn. Lab. Immunol. 9:1039-1043.
10. Ampel, N. M., D. G. Mosley, B. England, P. D. Vertz, K. Komatsu, and R. A. Hajjeh. 1998. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin. Infect. Dis. 27:1528-1530.
11. Armstrong, J. A., and P. D'Arcy Hart. 1971. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes and phagosomes. J. Exp. Med. 134:713-740.
12. Arsura, E. L. 1997. The association of age and mortality in coccidioidomycosis. J. Am. Geriatr. Soc. 45:532-533.
13. Arsura, E. L., W. B. Kilgore, J. W. Caldwell, J. C. Freeman, H. E. Einstein, and R. H. Johnson. 1998. Association between facial cutaneous coccidioidomycosis and meningitis. West. J. Med. 169:13-16.
14. Baker, D., and A. I. Braude. 1956. A study of stimuli leading to the production of spherules in coccidioidomycosis. J. Lab. Clin. Med. 47:169-181.
15. Barbee, R. A., M. J. Hicks, D. Grosso, and C. Sandel. 1991. The maternal immune response in coccidioidomycosis. Is pregnancy a risk factor for serious infection? Chest 100:709-715.
16. Barnato, A. E., G. D. Sanders, and D. K. Owens. 2001. Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg. Infect. Dis. 7:797-806.
17. Barry, M. A., W. C. Lai, and S. A. Johnston. 1995. Protection against mycoplasma infection using expression-library immunization. Nature 377: 632-635.
18. Beaman, L. 1991. Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis. Infect. Immun. 59:4227-4229.
19. Beaman, L. 1987. Fungicidal activation of murine macrophages by recombinant gamma interferon. Infect. Immun. 55:2951-2955.
20. Beaman, L., E. Benjamini, and D. Pappagianis. 1983. Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect. Immun. 39:1201-1207.
21. Beaman, L., E. Benjamini, and D. Pappagianis. 1981. Role of lymphocytes in macrophage-induced killing of Coccidioides immitis, in vitro. Infect. Immun. 34:347-353.
22. Beaman, L., and C. A. Holmberg. 1980. In vitro response of alveolar macrophages to infection with Coccidioides immitis. Infect. Immun. 28:594-600.
23. Beaman, L., and C. A. Holmberg. 1980. Interaction of nonhuman primate peripheral blood leukocytes and Coccidioides immitis in vitro. Infect. Immun. 29:1200-1201.
24. Beaman, L., and D. Pappagianis. 1985. Fate of Coccidioides immitis arthroconidia in human peripheral blood monocyte cultures in vitro, p. 170-180. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 4th International Conference. National Foundation for Infectious Disease, Washington, D.C.
25. Beaman, L., D. Pappagianis, and E. Benjamini. 1977. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect. Immun. 17:580-585.
26. Beaman, L. V., D. Pappagianis, and E. Benjamini. 1979. Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect. Immun. 23:681-685.
27. Becker, S., R. B. Devlin, and J. S. Haskill. 1989. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages. J. Leukoc. Biol. 45:353-361.
28. Brazolot Millan, C. L., R. Weeratna, A. M. Krieg, C. A. Siegrist, and H. L. Davis. 1998. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95:15553-15558.
29. Breslau, A. M., and M. Y. Kubota. 1964. Continuous in vitro cultivation of spherules of Coccidioides immitis. J. Bacteriol. 87:468-472.
30. Britt, R. H., D. R. Enzmann, and J. S. Remington. 1981. Intracranial infection in cardiac transplant recipients. Ann. Neurol. 9:107-119.
31. Brummer, E., L. Beaman, and D. A. Stevens. 1985. Killing of endospores, but not arthroconididia of Coccidioides immitis by immunologically activated polymorphoneclear neutrophils, p. 201-213. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 4th International Conference. National Foundation for Infectious Disease, Washington, D.C.
32. Burt, A., D. A. Carter, G. L. Koenig, T. J. White, and J. W. Taylor. 1996. Molecular markers reveal cryptic sex in the human pathogen Coccidioides immitis. Proc. Natl. Acad. Sci. USA 93:770-773.
33. Burt, A., D. A. Carter, T. J. White, and J. W. Taylor. 1994. DNA sequencing with arbitrary primer pairs. Mol. Ecol. 3:523-525.
34. Burt, A., B. M. Dechairo, G. L. Koenig, D. A. Carter, T. J. White, and J. W. Taylor. 1997. Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas. Mol. Ecol. 6:781-786.
35. Buschman, E., and E. Skamene. 2001. From Bcg/Lsh/Ity to Nramp1: three decades of search and research. Drug. Metab. Dispos. 29:471-473.
36. Butt, E. M., and A. M. Hoffman. 1945. Healed or arrested pulmonary coccidioidomycosis; correlation of coccidioidin skin tests with autopsy findings. Am. J. Pathol. 21:485-505.
37. Cairns, L., D. Blythe, A. Kao, D. Pappagianis, L. Kaufman. J. Kobayashi, and R. Hajjeh. 2000. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin. Infect. Dis. 30:61-64.
38. Caldwell, J. W., E. L. Arsura, W. B. Kilgore, A. L. Garcia, V. Reddy, and R. H. Johnson. 2000. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet. Gynecol. 95:236-239.
39. Calhoun, D. L., E. O. Osir, K. O. Dugger, J. N. Galgiani, and J. H. Law. 1986. Humoral antibody responses to specific antigens of Coccidioides immitis. J. Infect. Dis. 154:265-272.
40. Carpentier, A. F., G. Auf, and J. Y. Delattre. 2003. CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma. Front. Biosci. 8:e115-e127.
41. Carroll, G. F., L. D. Haley, and J. M. Brown. 1977. Primary cutaneous coccidioidomycosis: a review of the literature and a report of a new case. Arch. Dermatol. 113:933-936.
42. Casadevall, A., M. Feldmesser, and L. A. Pirofski. 2002. Induced humoral immunity and vaccination against major human fungal pathogens. Curr. Opin. Microbiol. 5:386-391.
43. Castleberry, M. W., J. L. Converse, and P. J. Soto, Jr. 1964. Antibiotic control of tissue reactions in dogs vaccinated with viable cells of Coccidioides immitis. J. Bacteriol. 87:1216-1220.
44. Catanzaro, A., L. E. Spitler, and K. M. Moser. 1975. Cellular immune response in coccidioidomycosis. Cell. Immunol. 15:360-371.
45. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-787.
46. Centers for Disease Control and Prevention. 2001. Coccidioidomycosis among persons attending the world championship of model airplane flying-Kern County, California, October 2001. Morb. Mortal. Wkly. Rep. 50:1106-1107.
47. Centers for Disease Control and Prevention. 1994. Coccidioidomycosis following the Northridge earthquake-California, 1994. Morb. Mortal. Wkly. Rep. 43:194-195.
48. Centers for Disease Control and Prevention. 2000. Coccidioidomycosis in travelers returning from Mexico-Pennsylvania, 2000. Morb. Mortal. Wkly. Rep. 49:1004-1006.
49. Centers for Disease Control and Prevention. 2001. Coccidioidomycosis in workers at an archeologic site-Dinosaur National Monument, Utah, June-July 2001. Morb. Mortal. Wkly. Rep. 50:1005-1008.
50. Centers for Disease Control and Prevention. 2003. Increase in coccidioidomycosis-Arizona, 1998-2001. Morb. Mortal. Wkly. Rep. 52:109-112.
51. Centers for Disease Control and Prevention. 2002. Laboratory security and emergency response guide for laboratories working with select agents. Morb. Mortal. Wkly. Rep. 51:1-6.
52. Centers for Disease Control and Prevention. 1994. Update: coccidioidomycosis-California, 1991-1993. Morb. Mortal. Wkly. Rep. 43:421-423.
53. Chaturvedi, V., R. Ramani, S. Gromadzki, B. Rodeghier, H. G. Chang, and D. L. Morse. 2000. Coccidioidomycosis in New York State. Emerg. Infect. Dis. 6:25-29.
54. Clemons, K. V., C. R. Leathers, and K. W. Lee. 1985. Systemic Coccidioides immitis infection in nude and beige mice. Infect. Immun. 47:814-821.
55. Cole, G. T., C.-Y. Hung, and N. Delgado. 2002. Parasite phase-specific gene expression in Coccidioides. ASM News 68:603-610.
56. Cole, G. T., T. N. Kirkland, and S. H. Sun. 1987. An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis. Infect. Immun. 55:657-667.
57. Cole, G. T., K. R. Seshan, M. Franco, E. Bukownik, S. H. Sun, and V. M. Hearn. 1988. Isolation and morphology of an immunoreactive outer wall fraction produced by spherules of Coccidioides immitis. Infect. Immun. 56:2686-2694.
58. Cole, G. T., and S. H. Sun. 1985. Arthroconidium-spherule-endospore transformation in Coccidioides immitis, p. 281-333. In P. J. Szaniszlo (ed.), Fungal dimorphism: with emphasis on fungi pathogenic for humans. Plenum Publishing Corp., New York, N.Y.
59. Converse, J. L. 1956. Effect of physio-chemical environment of spherulation of Coccidioides immitis in a chemically defined medium. J. Bacteriol. 72: 784-792.
60. Converse, J. L. 1957. Effect of surface active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J. Bacteriol. 74:106-107.
61. Converse, J. L. 1955. Growth of spherules of Coccidioides immitis in a chemically defined liquid medium. Proc. Soc. Exp. Biol. Med. 90:709-711.
62. Converse, J. L., and A. R. Besemer. 1959. Experimental primary cutaneous coccidioidomycosis in the monkey. J. Bacteriol. 87:81-85.
63. Converse, J. L., and A. R. Besemer. 1959. Nutrition of the parasitic phase of Coccidioides immitis in a chemically defined medium. J. Bacteriol. 78: 231-239.
64. Converse, J. L., M. W. Castleberry, A. R. Besemer, and E. M. Snyder. 1962. Immunization of mice against coccidioidomycosis. J. Bacteriol. 84:46-52.
65. Converse, J. L., M. W. Castleberry, and E. M. Snyder. 1963. Experimental viable vaccine against pulmonary coccidioidomycosis in monkeys. J. Bacteriol. 86:1041-1051.
66. Corry, D. B., N. M. Ampel, L. Christian, R. M. Locksley, and J. N. Galgiani. 1996. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J. Infect. Dis. 174:440-443.
67. Cox, R. A. 1989. Antigenic structure of Coccidioides immitis. Immunol. Ser. 47:133-170.
68. Cox, R. A. 1989. Coccidioidomycosis, p. 165-197. In R. A. Cox (ed.), Immunology of fungal diseases. CRC Press, Inc., Boca Raton, Fla.
69. Cox, R. A., and D. R. Arnold. 1979. Immunoglobulin E in coccidioidomycosis. J. Immunol. 123:194-200.
70. Cox, R. A., B. S. Baker, and D. A. Stevens. 1982. Specificity of immunoglobulin E in coccidioidomycosis and correlation with disease involvement. Infect. Immun. 37:609-616.
71. Cox, R. A., and L. A. Britt. 1985. Antigenic heterogeneity of an alkali-soluble, water-soluble cell wall extract of Coccidioides immitis. Infect. Immun. 50:365-369.
72. Cox, R. A., and L. A. Britt. 1987. Antigenic identity of biologically active antigens in coccidioidin and spherulin. Infect. Immun. 55:2590-2596.
73. Cox, R. A., and L. A. Britt. 1986. Isolation and identification of an exoantigen specific for Coccidioides immitis. Infect. Immun. 52:138-143.
74. Cox, R. A., and L. A. Britt. 1986. Isolation of a coccidioidin component that reacts with immunoglobulin M precipitin antibody. Infect. Immun. 53:449-453.
75. Cox, R. A., E. Brummer, and G. Lecara. 1977. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect. Immun. 15: 751-755.
76. Cox, R. A., M. J. Dolan, D. M. Magee, and J. N. Galgiani. 1993. Production of a murine monoclonal antibody that recognizes an epitope specific to Coccidioides immitis antigen 2. Infect. Immun. 61:1895-1899.
77. Cox, R. A., W. Kennell, L. Boncyk, and J. W. Murphy. 1988. Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect. Immun. 56:13-17.
78. Cox, R. A., and D. M. Magee. 1995. Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis. Infect. Immun. 63:4178-4180.
79. Cox, R. A., and D. M. Magee. 1998. Protective immunity in coccidioidomycosis. Res. Immunol. 149:417-428, 506-507.
80. Cox, R. A., and R. M. Pope. 1987. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis. Infect. Immun. 55: 1058-1062.
81. Cox, R. A., R. M. Pope, and D. A. Stevens. 1982. Immune complexes in coccidioidomycosis. Correlation with disease involvement. Am. Rev. Respir. Dis. 126:439-443.
82. Cox, R. A., and J. R. Vivas. 1977. Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis. Cell. Immunol. 31:130-141.
83. Crum, N., C. Lamb, G. Utz, D. Amundson, and M. Wallace. 2002. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area-Coalinga, California. J. Infect. Dis. 186:865-868.
84. Currah, R. S. 1985. Taxonomy of Onygenales: Arthrodermataceae, Gymnoascacease, Myxotrichaceae, and Onygenaceae. Mycotaxon 24:1-216.
85. Davis, H. L., R. Weeratna, T. J. Waldschmidt, L. Tygrett, J. Schorr, A. M. Krieg, and R. Weeranta. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870-876.
86. De Groot, A. S., A. Bosnia, N. Chinai, J. Frost, B. M. Jesdale, M. A. Gonzalez, W. Martin, and C. Saint-Aubin. 2001. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 19:4385-4395.
87. De Groot, A. S., B. M. Jesdale, E. Szu, J. R. Schafer, R. M. Chicz, and G. Deocampo. 1997. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res. Hum. Retroviruses 13:529-531.
88. De Groot, A. S., H. Sbai, C. S. Aubin, J. McMurry, and W. Martin. 2002. Immune-informatics: mining genomes for vaccine components. Immunol. Cell Biol. 80:255-269.
89. Delgado, N., J. Xue, J. J. Yu, C. Y. Hung, and G. T. Cole. 2003. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect. Immun. 71:3010-3019.
90. Department of Health and Human Services. 2002. Possession, use, and transfer of select agents and toxins. 42 CFR, Part 73. Fed. Regist. 240: 76886-76905.
91. Deresinski, S. C., D. Pappagianis, and D. A. Stevens. 1979. Association of ABO blood group and outcome of coccidioidal infection. Sabouraudia 17:261-264.
92. Desai, S. A., O. A. Minai, S. M. Gordon, B. O'Neil, H. P. Wiedemann, and A. C. Arroliga. 2001. Coccidioidomycosis in non-endemic areas: a case series. Respir. Med. 95:305-309.
93. Dickson, E. C. 1937. "Valley Fever" of the San Joaquin Valley and fungus Coccidioides. Calif. West. Med. 47:151-155.
94. Dixon, D. M. 2001. Coccidioides immitis as a select agent of bioterrorism. J. Appl. Microbiol. 91:602-605.
95. Dodd, L. G., and S. D. Nelson. 1990. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am. J. Clin. Pathol. 93:141-144.
96. Dodge, R. R., M. D. Lebowitz, R. A. Barbee, and B. Burrows. 1985. Immediate reactions to coccidioidin and spherulin: the relation of atopy to coccidioidomycosis, p. 214-223. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 4th International Conference. National Foundation for Infectious Disease, Washington. D.C.
97. Dooley, D. P., R. A. Cox, K. L. Hestilow, M. J. Dolan, and D. M. Magee. 1994. Cytokine induction in human coccidioidomycosis. Infect. Immun. 62:3980-3983.
98. Drutz, D. J., and A. Catanzaro. 1978. Coccidioidomycosis. Part I. State of the art. Am. Rev. Respir. Dis. 117:559-585.
99. Drutz, D. J., and A. Catanzaro. 1978. Coccidioidomycosis. Part II. State of the art. Am. Rev. Respir. Dis. 117:727-770.
100. Drutz, D. J., and M. Huppert. 1983. Coccidioidomycosis: factors affecting the host-parasite interaction. J. Infect. Dis. 147:372-390.
101. Drutz, D. J., M. Huppert, S. H. Sun, and W. L. McGuire. 1981. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect. Immun. 32:897-907.
102. Dugger, K. O., and J. N. Galgiani. 1989. Neutrophil killing of single microorganisms as measured by a new method. Diagn. Microbiol. Infect. Dis. 3:199-203.
103. Dugger, K. O., J. N. Galgiani, N. M. Ampel, S. H. Sun, D. M. Magee, J. Harrison, and J. H. Law. 1991. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect. Immun. 59:2245-2251.
104. Dugger, K. O., K. M. Villareal, A. Ngyuen, C. R. Zimmermann, J. H. Law, and J. N. Galgiani. 1996. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem. Biophys. Res. Commun. 218:485-489.
105. Durry, E., D. Pappagianis, S. B. Werner, L. Hutwagner, R. K. Sun, M. Maurer, M. M. McNeil, and R. W. Pinner. 1997. Coccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease. J. Med. Vet. Mycol. 35:321-326.
106. Echols, R. M., D. L. Palmer, and G. W. Long. 1982. Tissue eosinophilia in human coccidioidomycosis. Rev. Infect. Dis. 4:656-664.
107. Edwards, A. D., S. P. Manickasingham, R. Sporri, S. S. Diebold, O. Schulz, A. Sher, T. Kaisho. S. Akira, and C. Reis e Sousa. 2002. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169:3652-3660.
108. Einstein, H. E., and R. H. Johnson. 1993. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin. Infect. Dis. 16:349-354.
109. Endres, R., M. B. Alimzhanov, T. Plitz, A. Futterer, M. H. Kosco-Vilbois, S. A. Nedospasov, K. Rajewsky, and K. Pfeffer. 1999. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J. Exp. Med. 189:159-168.
110. Fierer, J., and T. Kirkland. 2002. Questioning CDCs "Select Agent" criteria. Science 295:43.
111. Fierer, J., L. Walls, L. Eckmann, T. Yamamoto, and T. N. Kirkland. 1998. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect. Immun. 66:4397-4402.
112. Fierer, J., L. Walls, and T. N. Kirkland. 2000. Genetic evidence for the role of the Lv locus in early susceptibility but not IL-10 synthesis in experimental coccidioidomycosis in C57BL mice. J. Infect. Dis. 181:681-685.
113. Fierer, J., L. Walls, F. Wright, and T. N. Kirkland. 1999. Genes influencing resistance to Coccidioides immitis and the interleukin-10 response map to chromosomes 4 and 6 in mice. Infect. Immun. 67:2916-2919.
114. Fiese, M. J. 1958. Coccidioidomycosis. Charles C Thomas, Springfield, Il.
115. Fish, D. G., N. M. Ampel, J. N. Galgiani, C. L. Dois, P. C. Kelly, C. H. Johnson, D. Pappagianis, J. E. Edwards, R. B. Wasserman, R. J. Clark, and et al. 1990. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 69:384-391.
116. Fisher, M. C., G. Koenig, T. J. White, and J. W. Taylor. 2002. Molecular and phenotypic description of Coccidioides posadasii sp.nov., previously recognized as the non-California population of Coccidoides immitis. Mycologia 94:73-84.
117. Fisher, M. C., G. Koenig, T. J. White, and J. W. Taylor. 2000. A test for concordance between the multilocus genealogies of genes and microsatellites in the pathogenic fungus Coccidioides immitis. Mol. Biol. Evol. 17: 1164-1174.
118. Fisher, M. C., G. L. Koenig, T. J. White, G. San-Bias, R. Negroni, I. G. Alvarez, B. Wanke, and J. W. Taylor. 2001. Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration. Proc. Natl. Acad. Sci. USA 98:4558-4562.
119. Fisher, M. C., T. J. White, and J. W. Taylor. 1999. Primers for genotyping single nucleotide polymorphisms and microsatellites in the pathogenic fungus Coccidioides immitis. Mol. Ecol. 8:1082-1084.
120. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
121. Foley, J. M., R. J. Berman, and C. E. Smith. 1960. X-ray irradiation of Coccidioides immitis arthrospores: survival curves and avirulent mutants isolated. J. Bacteriol. 79:480-487.
122. Forbus, W., and A. M. Bestebreurtje. 1946. Coccidioidomycosis: a study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease. Mil. Surg. 5:653-719.
123. Frey, C. L., and D. J. Drutz. 1986. Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J. Infect. Dis. 153:933-943.
124. Friedman, L., and C. E. Smith. 1956. Vaccination of mice against Coccidioides immitis. Am. Rev. Tuber. Pulm. Dis. 74:245-248.
125. Galgiani, J. N. 1993. Coccidioidomycosis. West. J. Med. 159:153-171.
126. Galgiani, J. N. 1986. Inhibition of different phases of Coccidioides immitis by human neutrophils or hydrogen peroxide. J. Infect. Dis. 153:217-222.
127. Galgiani, J. N. 1985. Potential role of human polymorphonuclear leukocytes in the early host response to Coccidioides immitis, p. 181-190. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 4th International Conference. National Foundation for Infectious Diseases, Washington, D.C.
128. Galgiani, J. N., R. Hayden, and C. M. Payne. 1982. Leukocyte effects on the dimorphism of Coccidioides immitis. J. Infect. Dis. 146:56-63.
129. Galgiani, J. N., R. A. Isenberg, and D. A. Stevens. 1978. Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. Infect. Immun. 21:862-865.
130. Galgiani, J. N., C. M. Payne, and J. F. Jones. 1984. Human polymorphonuclear-leukocyte inhibition of incorporation of chitin precursors into mycelia of Coccidioides immitis. J. Infect. Dis. 149:404-412.
131. Galgiani, J. N., S. H. Sun, K. O. Dugger, N. M. Ampel, G. G. Grace, J. Harrison, and M. A. Wieden. 1992. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination. Infect. Immun. 60:2627-2635.
132. Garcia, I., Y. Miyazaki, G. Marchal, W. Lesslauer, and P. Vassalli. 1997. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas. Eur. J. Immunol. 27:3182-3190.
133. Gifford, J., and A. Catanzaro. 1981. A comparison of coccidioidin and spherulin skin testing in the diagnosis of coccidioidomycosis. Am. Rev. Respir. Dis. 124:440-444.
134. Gifford, M. A., W. C. Buss, and R. J. Douds. 1937. Data on Coccidioides fungus infection, Kern County, 1900-1936. Kern County Health Department Annual Report, p. 39-54. Kern County Health Department, Bakersfield, Calif.
135. Goldstein, D. M., and S. Louie. 1943. Primary pulmonary coccidioidomycosis. Report of an epidemic of seventy five cases. War Med. 4:299-317.
136. Harris, R. E. 1966. Coccidioidomycosis complicating pregnancy. Report of three cases and review of the literature. Obstet. Gynecol. 28:401-405.
137. Harrison, H. N. 1958. Fatal maternal coccidioidomycosis: a case report and review of sixteen cases from the literature. Am. J. Obstet. Gynecol. 75:813-820.
138. Hartmann, G., R. D. Weeratna, Z. K. Ballas, P. Payette, S. Blackwell, I. Suparto, W. L. Rasmussen, M. Waldschmidt, D. Sajuthi, R. H. Purcell, H. L. Davis, and A. M. Krieg. 2000. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164:1617-1624.
139. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
140. Hicks, H. R., and W. T. Northey. 1967. Studies on the response of thymectomized mice to infection with Coccidioides immitis, p. 183-187. In L. Ajello (ed.), Proceedings of Second Coccidioidomycosis Symposium. University of Arizona Press, Tucson.
141. Hodge-Dufour, J., M. W. Marino, M. R. Horton, A. Jungbluth, M. D. Burdick, R. M. Strieter, P. W. Noble, C. A. Hunter, and E. Pure. 1998. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 95:13806-13811.
142. Hung, C. Y., N. M. Ampel, L. Christian, K. R. Seshan, and G. T. Cole. 2000. A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses. Infect. Immun. 68:584-593.
143. Hung, C. Y., J. J. Yu, K. R. Seshan, V. Reichard, and G. T. Cole. 2002. A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory fungal pathogen. Infect. Immun. 70:3443-3456.
144. Huppert, M. 1978. Racism in coccidioidomycosis? Am. Rev. Respir. Dis. 118:797-798.
145. Huppert, M., J. P. Adler, E. H. Rice, and S. H. Sun. 1979. Common antigens among systemic disease fungi analyzed by two-dimensional immunoelectrophoresis. Infect. Immun. 23:479-485.
146. Huppert, M., H. B. Levine, S. H. Sun, and E. T. Peterson. 1967. Resistance of vaccinated mice to typical and atypical strains of Coccidioides immitis. J. Bacteriol. 94:924-947.
147. Huppert, M., N. S. Spratt, K. R. Vukovich, S. H. Sun, and E. H. Rice. 1978. Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis. Infect. Immun. 20:541-551.
148. Huppert, M., S. H. Sun, and J. L. Harrison. 1982. Morphogenesis throughout saprobic and parasitic cycles of Coccidioides immitis. Mycopathologia 78:107-122.
149. Hyde, L. 1968. Coccidioidal pulmonary cavitation. Dis. Chest 54(Suppl. 1):273-277.
150. Ivey, F. D., D. M. Magee, M. D. Woitaske, S. A. Johnston, and R. A. Cox. 2003. Identification of a protective antigen of Coccidioides immitis by expression library immunization. Vaccine 21:4359.
151. Jiang, C., D. M. Magee, and R. A. Cox. 1999. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect. Immun. 67:5848-5853.
152. Jiang, C., D. M. Magee, and R. A. Cox. 1999. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect. Immun. 67: 2996-3001.
153. Jiang, C., D. M. Magee, F. D. Ivey, and R. A. Cox. 2002. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis. Infect. Immun. 70:3539-3545.
154. Jiang, C., D. M. Magee, T. N. Quitugua, and R. A. Cox. 1999. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect. Immun. 67:630-635.
155. Johnson, A. G. 1994. Molecular adjuvants and immunomodulators: new approaches to immunization. Clin. Microbiol. Rev. 7:277-289.
156. Johnson, D. A., D. S. Keegan, C. G. Sowell, M. T. Livesay, C. L. Johnson, L. M. Taubner, A. Harris, K. R. Myers, J. D. Thompson, G. L. Gustafson, M. J. Rhodes, J. T. Ulrich, J. R. Ward, Y. M. Yorgensen, J. L. Cantrell, and V. G. Brookshire. 1999. 3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities. J. Med. Chem. 42:4640-4649.
157. Johnson, R. H., J. W. Caldwell, G. Welch, and H. E. Einstein. 1996. The great coccidioidomycosis epidemic: clinical features, p. 77-87. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 5th International Conference. National Foundation for Infectious Diseases, Washington, D.C.
158. Kashkin, K. P., S. M. Likholetov, and A. V. Lipnitsky. 1977. Studies on mediators of cellular immunity in experimental coccidioidomycosis. Sabouraudia 15:59-68.
159. Kaufman, L., and P. Standard. 1978. Immuno-identification of cultures of fungi pathogenic to man. J. Clin. Microbiol. 1:135-140.
160. Kennev, R. T., N. Regina Rabinovich, S. Pichyangkul, V. L. Price, and H. D. Engers. 2002. 2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Sante Fondation Merieux, Annecy, France, 5-7 June 2000. Vaccine 20: 2155-2163.
161. Kensil. C. R. 1996. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst. 13:1-55.
162. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
163. Kirkland, T., and G. T. Cole. 2002. Coccidioidomycosis: pathogenesis, immune response, and vaccine development, p. 365-400. In R. A. Calderone and R. L. Cihlar (ed.), Fungal pathogenesis: principles and clinical applications. Marcel Dekker, Inc., New York, N.Y.
164. Kirkland, T. N., and J. Fierer. 1985. Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J. Immunol. 135:548-552.
165. Kirkland, T. N., and J. Fierer. 1986. Genetics of resistance to coccidioidomycosis, p. 169-171. In L. Leive (ed.), Microbiology-1986. American Society for Microbiology, Washington, D.C.
166. Kirkland, T. N., and J. Fierer. 1983. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. Infect. Immun. 40:912-916.
167. Kirkland, T. N., F. Finley, K. I. Orsborn, and J. N. Galgiani. 1998. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect. Immun. 66:3519-3522.
168. Kirkland, T. N., P. W. Thomas, F. Finley, and G. T. Cole. 1998. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis. Infect. Immun. 66:424-431.
169. Kirkland, T. N., S. W. Zhu, D. Kruse, L. L. Hsu, K. R. Seshan, and G. T. Cole. 1991. Coccidioides immitis fractions which are antigenic for immune T lymphocytes. Infect. Immun. 59:3952-3961.
170. Kolivras, K. N., and A. C. Comrie. 2003. Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int. J. Biometeorol. 47:87-101.
171. Kolivras, K. N., P. Johnson, A. C. Comrie, and S. R. Yool. 2001. Environmental variability and coccidioidomycosis (valley fever). Aerobiologia 17: 31-42.
172. Kong, Y. M., H. B. Levine, and C. E. Smith. 1963. Immunogenic properties of nondisrupted and disrupted spherules of Coccidioides immitis in mice. Sabouraudia 2:131-142.
173. Kong, Y. M., and H. B. Levine. 1967. Experimentally induced immunity in the mycoses. Bacteriol. Rev. 31:35-53.
174. Kong, Y. M., and H. B. Levine. 1967. Loss and recovery of virulence of arthrospores and spherule-endospores of Coccidioides immitis in live vaccines, p. 189-195. In L. Ajello (ed.), Proceedings of the Second Coccidioidomycosis Symposium. University of Arizona Press, Tucson.
175. Kong, Y. M., D. C. Savage, and H. B. Levine. 1965. Enhancement of immune responses in mice by a booster injection of Coccidioides spherules. J. Immunol. 95:1048-1056.
176. Koufopanou, V., A. Burt, T. Szaro, and J. W. Taylor. 2001. Gene genealogies, cryptic species, and molecular evolution in the human pathogen Coccidioides immitis and relatives (Ascomycota, Onygenales). Mol. Biol. Evol. 18:1246-1258.
177. Koufopanou, V., A. Burt, and J. W. Taylor. 1997. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis. Proc. Natl. Acad. Sci. USA 94:5478-5482.
178. Krieg, A. M., A. K. Yi, J. Schorr, and H. L. Davis. 1998. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6:23-27.
179. Lacy, G. H., and F. E. Swatek. 1977. Coccidioides in California, p. 107-114. In L. Ajello (ed.), Coccidioidomycosis: current clinical and diagnostic status. Symposia Specialists, Miami, Fla.
180. Lacy, G. H., and F. E. Swatek. 1974. Soil ecology of Coccidioides immitis at Amerindian middens in California. Appl. Microbiol. 27:379-388.
181. Le, J., and J. Vilcek. 1987. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Investig. 56:234-248.
182. Leake, J. A., D. G. Mosley, B. England, J. V. Graham, B. D. Plikaytis, N. M. Ampel, B. A. Perkins, and R. A. Hajjeh. 2000. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J. Infect. Dis. 181:1435-1440.
183. Lecara, G., R. A. Cox, and R. B. Simpson. 1983. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect. Immun. 39:473-475.
184. Levine, H. B., J. M. Cobb, and G. M. Scalarone. 1969. Spherule coccidioidin in delayed dermal sensitivity reactions of experimental animals. Sabouraudia 7:20-32.
185. Levine, H. B., J. M. Cobb, and C. E. Smith. 1960. Immunity to coccidioidomycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans. N. Y. Acad. Sci. 22:436-449.
186. Levine, H. B., J. M. Cobb, and C. E. Smith. 1961. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J. Immunol. 87:218-227.
187. Levine, H. B., Y. C. Kong, and C. Smith. 1965. Immunization of mice to Coccidioides immitis: dose, regimen and spheralation stage of killed spherule vaccines. J. Immunol. 94:132-142.
188. Levine, H. B., R. L. Miller, and C. E. Smith. 1962. Influence of vaccination on respiratory coccidioidal disease in cynomologous monkeys. J. Immunol. 89:242-251.
189. Li, K., J. J. Yu, C. Y. Hung, P. F. Lehmann, and G. T. Cole. 2001. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice. Infect. Immun. 69:2878-2887.
190. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-262.
191. Louie, L., S. Ng, R. Hajjeh, R. Johnson, D. Vugia, S. B. Werner, R. Talbot, and W. Klitz. 1999. Influence of host genetics on the severity of coccidioidomycosis. Emerg. Infect. Dis. 5:672-680.
192. Lubarsky, R., and O. A. Plunkett. 1955. Some ecologic studies of Coccidioides immitis in soil, p. 308-310. In T. H. Sternberg and V. D. Newcomer (ed.), Therapy of fungus diseases. An international symposium. Little, Brown, & Co., Boston, Mass.
193. MacLeod, R., S. Nagel, M. Kaufmann, K. Grenlich-Bode, and H. Drexler. 2002. Multicolor-FISH analysis of a natural killer cell line (NK-92). Leukoc. Res. 26:1027-1033.
194. Maddy, K. 1957. Ecological factors possibly relating to the geographic distribution of coccidioidomycosis. U.S. Public Health Service Publication 575. U.S. Public Health Service, Washington, D.C.
195. Magee, D. M., and R. A. Cox. 1996. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect. Immun. 64:3609-3613.
196. Magee, D. M., and R. A. Cox. 1995. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect. Immun. 63:3514-3519.
197. McNeil, M. M., and N. M. Ampel. 1995. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin. Infect. Dis. 21(Suppl. 1):S111-S113.
198. Meager, A., H. Leung, and J. Woolley. 1989. Assays for tumour necrosis factor and related cytokines. J. Immunol. Methods 116:1-17.
199. Meister, G. E., C. G. Roberts, J. A. Berzofsky, and A. S. De Groot. 1995. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 13:581-591.
200. Mirbod, F., R. A. Schaller, and G. T. Cole. 2002. Purification and characterization of urease isolated from the pathogenic fungus Coccidioides immitis. Med. Mycol. 40:35-44.
201. Moldoveanu, Z., L. Love-Homan, W. Q. Huang, and A. M. Krieg. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16:1216-1224.
202. Moreira, A. L., L. Tsenova-Berkova, J. Wang, P. Laochumroonvorapong, S. Freeman, V. H. Freedman, and G. Kaplan. 1997. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tubercle Lung. Dis. 78:47-55.
203. Moretta, A., C. Bottino, M. C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3:6-8.
204. Mourant, A. E., A. C. Kopec, and D. S. Kazmiera. 1959. The ABO blood groups. Blackwell Scientific Publishing, Oxford, United Kingdom.
205. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60: 4534-4541.
206. Naroeni, A., N. Jouy, S. Ouahrani-Bettache, J. P. Liautard, and F. Porte. 2001. Brucella suis-impaired specific recognition of phagosomes by lysosomes due to phagosomal membrane modifications. Infect. Immun. 69:486-493.
207. Olivere, J. W., P. A. Meier, S. L. Fraser, W. B. Morrison, T. W. Parsons, and D. M. Drehner. 1999. Coccidioidomycosis-the airborne assault continues: an unusual presentation with a review of the history, epidemiology, and military relevance. Aviat. Space. Environ. Med. 70:790-796.
208. Opelz, G., and M. I. Scheer. 1975. Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis. J. Infect. Dis. 132:250-255.
209. Ophuls, W., and H. C. Moffitt. 1900. A new pathogenic mould (formerly described as a protozoon: Coccidioides immitis pyogenes) preliminary report. Philadelphia Med. J. 5:1471-1472.
210. Pan, S., and G. T. Cole. 1995. Molecular and biochemical characterization of a Coccidioides immitis-specific antigen. Infect. Immun. 63:3994-4002.
211. Pan, S., L. Sigler, and G. T. Cole. 1994. Evidence for a phylogenetic connection between Coccidioides immitis and Uncinocarpus reesii (Onygenaceae). Microbiology 140:1481-1494.
212. Panackal, A. A., R. A. Hajjeh, M. S. Cetron, and D. W. Warnock. 2002. Fungal infections among returning travelers. Clin. Infect. Dis. 35:1088-1095.
213. Pappagianis, D. 1999. Coccidioides immitis antigen. J. Infect. Dis. 180:243-244.
214. Pappagianis, D. 1993. Coccidioidomycosis. Semin. Dermatol. 12:301-309.
215. Pappagianis, D. 1967. Epidemiological aspects of respiratory mycotic infections. Bacteriol. Rev. 31:25-34.
216. Pappagianis, D. 1988. Epidemiology of coccidioidomycosis. Curr. Top. Med. Mycol. 2:199-238.
217. Pappagianis, D. 1980. Epidemiology of coccidioidomycosis, p. 63-85. In D. A. Stevens (ed.), Coccidioidomycosis: a Text. Plenum Publishing Corp., New York, N. Y.
218. Pappagianis, D, and The Valley Fever Vaccine Study Group. 1993. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am. Rev. Respir. Dis. 148:656-660.
219. Pappagianis, D. 1994. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin. Infect. Dis. 19(Suppl. 1):S14-S18.
220. Pappagianis, D. 2001. Seeking a vaccine against Coccidioides immitis and serologie studies: expectations and realities. Fungal Genet. Biol. 32:1-9.
221. Pappagianis, D., and H. Einstein. 1978. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West. J. Med. 129:527-530.
222. Pappagianis, D., R. Hector, H. B. Levine, and M. S. Collins. 1979. Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect. Immun. 25:440-445.
223. Pappagianis, D., and H. B. Levine. 1975. The present status of vaccination against coccidioidomycosis in man. Am. J. Epidemiol. 102:30-41.
224. Pappagianis, D., H. B. Levine, C. E. Smith, R. J. Berman, and G. K. Kobayashi. 1961. Immunization of mice with viable Coccidioides immitis. J. Immunol. 86:28-34.
225. Pappagianis, D., S. Lindsay, S. Beall, and P. Williams. 1979. Ethnic background and the clinical course of coccidioidomycosis. Am. Rev. Respir. Dis. 120:959-961.
226. Pappagianis, D., N. J. Lindsey, C. E. Smith, and M. T. Saito. 1965. Antibodies in human coccidioidomycosis: immunoelectrophoretic properties. Proc. Soc. Exp. Biol. Med. 118:118-122.
227. Pappagianis, D., R. L. Miller, C. E. Smith, and G. S. Kobayashi. 1960. Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. Am. Rev. Respir. Dis. 82:244-250.
228. Payne, R., K. K. Kidd, P. Rodvany, and H. H. Perkins. 1973. HL-A and other polymorphisms of the Filipino people, p. 203-208. In J. Dausett and J. Colombani (ed.), Histocompatibility testing. The Williams & Wilkins Co., Baltimore, Md.
229. Peng, T., K. I. Orsborn, M. J. Orbach, and J. N. Galgiani. 1999. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation. J. Infect. Dis. 179:518-521.
230. Peng, T., L. Shubitz, J. Simons, R. Perrill, K. I. Orsborn, and J. N. Galgiani. 2002. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against Infection with Coccidioides immitis in mice. Infect. Immun. 70:3330-3335.
231. Petkus, A. F., and L. L. Baum. 1987. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis. J. Immunol. 139:3107-3111.
232. Pieters, J., and J. Gatfield. 2002. Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol. 10:142-146.
233. Pirofski, L. A., and A. Casadevall. 1996. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? Zentbl. Bakteriol. 284:475-495.
234. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Suva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
235. Posadas, A. 1892. Un nuevo caso de micosis fungoidea con psorospermias. An. Circ. Med. Argent. 15:585-597.
236. Powell, B. L., and D. J. Drutz. 1984. Identification of a high-affinity binder for estradiol and a low-affinity binder for testosterone in Coccidioides immitis. Infect. Immun. 45:784-786.
237. Powell, B. L., D. J. Drutz, M. Huppert, and S. H. Sun. 1983. Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect. Immun. 40:478-485.
238. Purtilo, D. T. 1975. Opportunistic mycotic infections in pregnant women. Am. J. Obstet. Gynecol. 122:607-610.
239. Rea, T. H., H. Einstein, R. Johnson, and N. E. Levan. 1977. Further study of dinitrochlorobenzene responsivity in disseminated coccidioidomycosis, p. 365-370. In L. Ajello (ed.), Coccidioidomycosis: current clinical and diagnostic status. Symposia Specialists, Miami, Fla.
240. Rea, T. H., H. Einstein, and N. E. Levan. 1976. Dinitrochlorobenzene responsivity in disseminated coccidioidomycosis: an inverse correlation with complement-fixing antibody titers. J. Investig. Dermatol. 66:34-37.
241. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495-498.
242. Requena, L., and C. Requena. 2002. Erythema nodosum. Dermatol. Online J. 8:1-32.
243. Richards, J. O., N. M. Ampel, J. N. Galgiani, and D. F. Lake. 2001. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation. J. Infect. Dis. 184:1220-1224.
244. Richards, J. O., N. M. Ampel, and D. F. Lake. 2002. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J. Immunol. 169:2020-2025.
245. Rixford, E., and T. C. Gilchrist. 1896. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp. Rev. 1:209-268.
246. Rook, G. A., J. Taverne, C. Leveton, and J. Steele. 1987. The role of gamma-imerferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 62:229-234.
247. Rosas, J. E., J. L. Pedraz, R. M. Hernandez, A. R. Gascon, M. Igartua, F. Guzman, R. Rodriguez, J. Cortes, and M. E. Patarroyo. 2002. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine 20:1707-1710.
248. Rosenstein, N. E., K. W. Emery, S. B. Werner, A. Kao, R. Johnson, D. Rogers, D. Vugia, A. Reingold, R. Talbot, B. D. Plikaytis, B. A. Perkins, and R. A. Hajjeh. 2001. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin. Infect. Dis. 32:708-715.
249. Russell, D. 1995. Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol. 5:125-128.
250. Sachidanandam, R., D. Weissman, S. C. Schmidt, J. M. Kakol, L. D. Stein, G. Marth, S. Sherry, J. C. Mullikin, B. J. Mortimore, D. L. Willey, S. E. Hunt, C. G. Cole, P. C. Coggill, C. M. Rice, Z. Ning, J. Rogers, D. R. Bentley, P. Y. Kwok, E. R. Mardis, R. T. Yeh, B. Schultz, L. Cook, R. Davenport, M. Dante, L. Fulton, L. Hillier, R. H. Waterston, J. D. McPherson, B. Gilman, S. Schaffner, W. J. Van Etten, D. Reich, J. Higgins, M. J. Daly, B. Blumenstiel, J. Baldwin, N. Stange-Thomann, M. C. Zody, L. Linton, E. S. Lander, and D. Altshuler. 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
251. Saeki, H., M. T. Wu, E. Olasz, and S. T. Hwang. 2000. A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo. Eur. J. Immunol. 30:2808-2814.
252. Salkin, D. 1967. Clinical examples of reinfection in coccidioidomycosis, p. 11-18. In L. Ajello (ed.), Proceedings of the Second Coccidioidomycosis Symposium. University of Arizona Press, Tucson.
253. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593-620.
254. Sarosi, G. A., J. D. Parker, I. L. Doto, and F. E. Tosh. 1970. Chronic pulmonary coccidioidomycosis. N. Engl. J. Med. 283:325-329.
255. Saunders, N. J., and E. R. Moxon. 1998. Implications of sequencing bacterial genomes for pathogenesis and vaccine development. Curr. Opin. Biotechnol. 9:618-623.
256. Savage, D. C., and S. H. Madin. 1968. Cellular responses in lungs of immunized mice to intranasal infection with Coccidioides immitis. Sabouraudia 6:94-102.
257. Schafer, J. R., B. M. Jesdale, J. A. George, N. M. Kouttab, and A. S. De Groot. 1998. Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. Vaccine 16:1880-1884.
258. Reference deleted.
259. Schermoly, M. J., and D. R. Hinthorn. 1988. Eosinophilia in coccidioidomycosis. Arch. Intern. Med. 148:895-896.
260. Schneider, E., R. A. Hajjeh, R. A. Spiegel, R. W. Jibson, E. L. Harp, G. A. Marshall, R. A. Gunn, M. M. McNeil, R. W. Pinner, R. C. Baron, R. C. Burger, L. C. Hutwagner, C. Crump, L. Kaufman, S. E. Reef, G. M. Feldman, D. Pappagianis, and S. B. Werner. 1997. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 277:904-908.
261. Seder, R. A., and S. Gurunathan. 1999. DNA vaccines-designer vaccines for the 21st century. N. Engl. J. Med. 341:277-278.
262. Segal, G. P., and A. Catanzaro. 1985. Genetic regulation of antibody responses to Coccidioides immitis: the role of antibody in mediated immunity, p. 191-200. In H. Einstein and A. Catanzaro (ed.), Coccidioidomycosis. Proceedings of the 4th International Conference. National Foundation for Infectious Disease, Washington, D.C.
263. Segal, G. P., R. I. Lehrer, and M. E. Selsted. 1985. In vitro effect of phagocyte cationic peptides on Coccidioides immitis. J. Infect. Dis. 151:890-894.
264. Shubitz. L., T. Peng, R. Perrill, J. Simons, K. Orsborn, and J. N. Galgiani. 2002. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect. Immun. 70:3287-3289.
265. Sievers, M. L. 1979. Coccidioidomycosis and race. Am. Rev. Respir. Dis. 119:839.
266. Sievers, M. L. 1974. Disseminated coccidioidomycosis among southwestern American Indians. Am. Rev. Respir. Dis. 109:602-612.
267. Sievers, M. L. 1977. Prognostic factors in disseminated coccidioidomycosis among southwestern American Indians, p. 63-78. In L. Ajello (ed.), Coccidioidomycosis: current clinical and diagnostic status. Symposia Specialists, Miami, Fla.
268. Sievers, M. L. 1980. Racial susceptibility to coccidioidomycosis. N. Engl. J. Med. 302:58-59.
269. Sigler, L., and J. W. Carmichael. 1976. Taxonomy of Malbranchea and some other hyphomycetes with arthroconidia. Mycotaxon 4:349-488.
270. Simms, P. E., and T. M. Ellis. 1996. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin. Diagn. Lab. Immunol. 3:301-304.
271. Singh, M., M. Briones, G. Ott, and D. O'Hagan. 2000. Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. USA 97:811-816.
272. Singh, M., and D. T. O'Hagan. 2002. Recent advances in vaccine adjuvants. Pharm. Res. 19:715-728.
273. Slagle, D. C., R. A. Cox, and U. Kuruganti. 1989. Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis. Infect. Immun. 57:1916-1921.
274. Smith, C. E. 1951. Annual progress report. Commission on Acute Respiratory Diseases. Armed Forces Epidemiological Board, Washington, D.C.
275. Smith, C. E. 1940. Epidemiology of acute coccidioidomycosis with erythema nodosum ("San Joaquin" or "Valley Fever"). Am. J. Public Health 30:600-611.
276. Smith, C. E. 1948. The use of coccidioidin. Am. Rev. Tuberc. 57:330-360.
277. Smith, C. E., R. R. Bard, E. G. Whiting, and H. G. Rosenberger. 1946. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am. J. Public Health 36:1394-1402.
278. Smith, C. E., R. R. Bard, H. G. Rosenberger, and E. G. Whiting. 1946. Effect of season and dust control on coccidioidomycosis. JAMA 132:833-838.
279. Smith, C. E., D. Pappagianis, H. B. Levine, and M. I. Saito. 1961. Human coccidioidomycosis. Bacteriol. Rev. 25:310-320.
280. Smith, C. E., M. T. Saito, R. R. Beard, R. M. Kepp, R. W. Clark, and B. U. Eddie. 1950. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am. J. Hyg. 52:1-20.
281. Smith, C. E., M. T. Saito, and S. A. Simons. 1956. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 160:546-552.
282. Standaert, S. M., W. Schaffner, J. N. Galgiani, R. W. Pinner, L. Kaufman, E. Durry, and R. H. Hutcheson. 1995. Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: an outbreak in a military reserve unit. J. Infect. Dis. 171:1672-1675.
283. Sternberg, S. 1994. The emerging fungal threat. Science 266:1632-1634.
284. Strasser, J. E., S. L. Newman, G. M. Ciraolo, R. E. Morris, M. L. Howell, and G. E. Dean. 1999. Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J. Immunol. 162: 6148-6154.
285. Stricter, R. M., D. G. Remick, J. P. Lynch, 3rd, M. Genord, C. Raiford, R. Spengler, and S. L. Kunkel. 1989. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am. J. Respir. Cell Mol. Biol. 1:57-63.
286. Sun, S. H., and M. Huppert. 1976. A cytological study of morphogenesis in Coccidioides immitis. Sabouraudia 14:185-198.
287. Sykes, K. F., and S. A. Johnston. 1999. Linear expression elements: a rapid, in vivo, method to screen for gene functions. Nat. Biotechnol. 17:355-359.
288. Sykes, K. F., M. G. Lewis, B. Squires, and S. A. Johnston. 2002. Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge. Vaccine 20:2382-2395.
289. Tarn, Y. K., B. Miyagawa, V. C. Ho, and H. G. Klingemann. 1999. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother. 8:281-290.
290. Thomas, P. W., E. E. Wyckoff, E. J. Pishko, J. J. Yu, T. N. Kirkland, and G. T. Cole. 1997. The hsp60 gene of the human pathogenic fungus Coccidioides immitis encodes a T-cell reactive protein. Gene 199:83-91.
291. VanBergen, W. S., F. J. Fleury, and E. L. Cheatle. 1976. Fatal maternal disseminated coccidioidomycosis in a nonendemic area. Am. J. Obstet. Gynecol. 124:661-663.
292. Vartivarian, S. E., P. E. Coudron, and S. M. Markowitz. 1987. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am. J. Med. 83:949-952.
293. Wack, E. E., N. M. Ampel, J. N. Galgiani, and D. A. Bronnimann. 1988. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest 94:376-379.
294. Walch, H. A., and A. Kalvoda. 1971. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines. Sabouraudia 9:173-184.
295. Wang, C. H., H. C. Lin, C. Y. Liu, K. H. Huang, T. T. Huang, C. T. Yu, and H. P. Kuo. 2001. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int. J. Tuberc. Lung. Dis. 5:283-291.
296. Wang, C. H., C. Y. Liu, H. C. Lin, C. T. Yu, K. F. Chung, and H. P. Kuo. 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11:809-815.
297. Wanke, B., M. Lazera, P. C. Monteiro, F. C. Lima, M. J. Leal, P. L. Ferreira Filho, L. Kaufman, R. W. Pinner, and L. Ajello. 1999. Investigation of an outbreak of endemic coccidioidomycosis in Brazil's northeastern state of Piaui with a review of the occurrence and distribution of Coccidioides immitis in three other Brazilian states. Mycopathologia 148:57-67.
298. Ward, E. R., Jr., R. A. Cox, J. A. Schmitt, Jr., M. Huppert, and S. H. Sun. 1975. Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis. Infect. Immun. 12:1093-1097.
299. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881-3888.
300. Warnock, D. W., B. Dupont, C. A. Kauffman, and T. Sirisanthana. 1998. Imported mycoses in Europe. Med. Mycol. 36(Suppl. 1):87-94.
301. Wegner, T. N., R. E. Reed, R. J. Trautman, and C. D. Beavers. 1972. Some evidence for the development of a phagocytic response by polymorphonuclear leukocytes recovered from the venous blood of dogs inoculated with Coccidioides immitis or vaccinated with an irradiated spherule vaccine. Am. Rev. Respir. Dis. 105:845-849.
302. Werner, S. B., and D. Pappagianis. 1973. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif. Med. 119:16-20.
303. Wernicke, R. 1892. Ueber einen Protozoenbefund bei Mycosis fungoides. Zentbl. Bakteriol. 12:859-861.
304. Wiant, J. R., and J. W. Smith. 1973. Coccidioidin skin reactivity in pulmonary coccidioidomycosis. Chest 63:100-102.
305. Wiater, L. A., K. Dunn, F. R. Maxfield, and H. A. Shuman. 1998. Early events in phagosome establishment are required for intracellular survival of Legionella pneumophila. Infect. Immun. 66:4450-4460.
306. Willett, F. M., and A. Weiss. 1945. Coccidioidomycosis in southern California: report of a new endemic area with a review of 100 cases. Ann. Intern. Med. 23:349-375.
307. Williams, F. M., V. Markides, J. Edgeworth, and A. J. Williams. 1998. Reactivation of coccidioidomycosis in a fit American visitor. Thorax 53: 811-812.
308. Williams, P. L., D. L. Sable, P. Mendez, and L. T. Smyth. 1979. Symptomatic coccidioidomycosis following a severe natural dust storm. An outbreak at the Naval Air Station, Lemoore, Calif. Chest 76:566-670.
309. Williams, P. L., D. L. Sable, S. P. Sorgen, D. Pappagianis, H. B. Levine, S. K. Brodine, B. W. Brown, F. C. Grumet, and D. A. Stevens. 1984. Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. Am. J. Epidemiol. 119:591-602.
310. Wilson, J. W., C. E. Smith, and O. A. Plunkett. 1953. Primary cutaneous coccidioidomycosis: criteria for diagnosis and report of a case. Calif. Med. 79:233-239.
311. Winn, W. A. 1968. A long term study of 300 patients with cavitary-abscess lesions of the lung of coccidioidal origin. An analytical study with special reference to treatment. Dis. Chest. S4(Suppl. 1):268.
312. Winn, W. A. 1965. Primary cutaneous coccidioidomycosis-reevaluation of its potentiality based on study of three new cases. Arch. Dermatol. 92:215-220.
313. Winn, W. A. 1967. A working classification of coccidioidomycosis and its application to therapy, p. 3-9. In L. Ajello (ed.), Proceedings of the Second Coccidioidomycosis Symposium. University of Arizona Press, Tucson.
314. Winn, W. A., S. M. Finegold, and R. W. Huntington. 1967. Coccidioidomycosis with fungemia, p. 93-109. In L. Ajello (ed.), Proceedings of the Second Coccidioidomycosis Symposium. University of Arizona Press, Tucson.
315. Woods, C. W., C. McRill, B. D. Plikaytis, N. E. Rosenstein, D. Mosley, D. Boyd, B. England, B. A. Perkins, N. M. Ampel, and R. A. Hajjeh. 2000. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: Incidence, risk factors, and prevention. J. Infect. Dis. 181:1428-1434.
316. Wyckoff, E. E., E. J. Pishko, T. N. Kirkland, and G. T. Cole. 1995. Cloning and expression of a gene encoding a T-cell reactive protein from Coccidioides immitis: homology to 4-hydroxyphenylpyruvate dioxygenase and the mammalian F antigen. Gene 161:107-111.
317. Yoshinoya, S., R. A. Cox, and R. M. Pope. 1980. Circulating immune complexes in coccidioidomycosis. Detection and characterization. J. Clin. Investig. 66:655-663.
318. Reference deleted.
319. Yu, J. J., S. L. Smithson, P. W. Thomas, T. N. Kirkland, and G. T. Cole. 1997. Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis. Gene 198:387-391.
320. + blood dendritic cells. Blood 86:3295-3301.
321. Zhu, Y., V. Tryon, D. M. Magee, and R. A. Cox. 1997. Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes. Infect. Immun. 65:3376-3380.
322. Reference deleted.
323. Zhu, Y., C. Yang, D. M. Magee, and R. A. Cox. 1996. Coccidioides immitis antigen 2: analysis of gene and protein. Gene 181:121-125.
324. Zhu, Y., C. Yang, D. M. Magee, and R. A. Cox. 1996. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA. Infect. Immun. 64:2695-2699.
325. Zimmermann, C. R., S. M. Johnson, G. W. Martens, A. G. White, B. L. Zimmer, and D. Pappagianis. 1998. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect. Immun. 66: 2342-2345.
326. Zimmermann, C. R., C. J. Snedker, and D. Pappagianis. 1994. Characterization of Coccidioides immitis isolates by restriction fragment length polymorphisms. J. Clin. Microbiol. 32:3040-3042.